[go: up one dir, main page]

AU2003266243A8 - 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors - Google Patents

1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors

Info

Publication number
AU2003266243A8
AU2003266243A8 AU2003266243A AU2003266243A AU2003266243A8 AU 2003266243 A8 AU2003266243 A8 AU 2003266243A8 AU 2003266243 A AU2003266243 A AU 2003266243A AU 2003266243 A AU2003266243 A AU 2003266243A AU 2003266243 A8 AU2003266243 A8 AU 2003266243A8
Authority
AU
Australia
Prior art keywords
pyrrolidine
hepatitis
cyano
carbonyl
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003266243A
Other versions
AU2003266243A1 (en
Inventor
Helen Susanne Goodland
David Haigh
Thomas W Ku
George Burton
Terence John Kiesow
Martin John Slater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003266243A1 publication Critical patent/AU2003266243A1/en
Publication of AU2003266243A8 publication Critical patent/AU2003266243A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003266243A 2002-07-22 2003-07-18 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors Abandoned AU2003266243A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0216985A GB0216985D0 (en) 2002-07-22 2002-07-22 Compounds
GB0216985.2 2002-07-22
PCT/EP2003/008138 WO2004009543A2 (en) 2002-07-22 2003-07-18 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors

Publications (2)

Publication Number Publication Date
AU2003266243A1 AU2003266243A1 (en) 2004-02-09
AU2003266243A8 true AU2003266243A8 (en) 2004-02-09

Family

ID=9940904

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003266243A Abandoned AU2003266243A1 (en) 2002-07-22 2003-07-18 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors

Country Status (3)

Country Link
AU (1) AU2003266243A1 (en)
GB (1) GB0216985D0 (en)
WO (1) WO2004009543A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0304494D0 (en) * 2003-02-27 2003-04-02 Glaxo Group Ltd Compounds
WO2006050035A1 (en) 2004-10-29 2006-05-11 Schering Corporation Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents
ES2381410T3 (en) 2007-05-04 2012-05-28 Vertex Pharmceuticals Incorporated Combination therapy for the treatment of HCV infections
US20130209403A1 (en) * 2010-09-08 2013-08-15 Ruprecht-Karls-Universitaet Use of inhibitors of phospholipase a2 for the treatment or prevention of flavivirus infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713502B2 (en) * 2000-05-05 2004-03-30 Smithkline Beecham Corporation Anti-infectives
EP1440068A1 (en) * 2001-11-02 2004-07-28 Glaxo Group Limited Acyl dihydro pyrrole derivatives as hcv inhibitors
EP1440070A1 (en) * 2001-11-02 2004-07-28 Glaxo Group Limited 4-(5-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors

Also Published As

Publication number Publication date
GB0216985D0 (en) 2002-08-28
WO2004009543A3 (en) 2004-03-18
WO2004009543A2 (en) 2004-01-29
AU2003266243A1 (en) 2004-02-09
WO2004009543A8 (en) 2004-06-10

Similar Documents

Publication Publication Date Title
IL182583A0 (en) 4-methoxymethyl-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors
SI1505963T1 (en) Hepatitis c virus inhibitors
EP1684787A4 (en) Hepatitis c virus inhibitors
EP1684745A4 (en) Hepatitis c virus inhibitors
PL371283A1 (en) Heterocyclic tripeptides as hepatitis c inhibitors
IL162673A0 (en) Pharmaceutical compositions for hepatitis c viral protease inhibitors
AU2003259155A1 (en) Pharmaceutical compositions comprising hepatitis c viral protease inhibitors
AU2003261434A8 (en) Iminothiazolidinones as inhibitors of hcv replication
PL377511A1 (en) Mandelic acid derivatives
AU2003293356A8 (en) Dihydropyridinone derivatives as hne inhibitors
AP2005003343A0 (en) Substituted pyrrolo-pyrazole derivatives as kinaseinhibitors
AP2406A (en) Macrocydic inhibitors of hepatitis C virus.
IL164729A0 (en) Nucleoside derivatives for treating hepatitis c virus infection
EP1572097A4 (en) Nucleoside derivatives for treating hepatitis c virus infection
PL372756A1 (en) Nicotinamide derivatives useful as pde4 inhibitors
SI1492785T1 (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
IL172876A0 (en) Substituted arylthiourea derivatives useful as inhibitors of viral replication
GB0203193D0 (en) Nicotinamide derivatives useful as pde4 inhibitors
AU2003272719A8 (en) Inhibitors of the nitrix oxide synthase iii (nos iii) as neuroprotective agents
AU2003294757A8 (en) Formulations useful against hepatitis c virus infections
AU2003266243A8 (en) 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
AU2006233207A1 (en) Hepatitis C virus inhibitors
HK1094429A (en) Hepatitis c virus inhibitors
HK1093919A (en) Hepatitis c virus inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase